Ann Knight

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis

Hellbacher, Erik; van Hoef, Vincent; Johansson, Alina; Knight, Ann et al.

Ingår i Frontiers in Immunology, 2025

• DOI för The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
• Ladda ner fulltext (pdf) av The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis

In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes

Lindberg, Hanna; Knight, Ann; Hellbacher, Erik; Norling, Olof et al.

Ingår i ACR Open Rheumatology, 2025

• DOI för In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes
• Ladda ner fulltext (pdf) av In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes

The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

Lundtoft, Christian; Knight, Ann; Meadows, Jennifer; Karlsson, Åsa et al.

Ingår i RMD Open, 2024

• DOI för The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population
• Ladda ner fulltext (pdf) av The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis

Sejersen, Kristina; Weitoft, Tomas; Knight, Ann; Lysholm, Jörgen et al.

Ingår i Rheumatology, 2023

• DOI för Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis
• Ladda ner fulltext (pdf) av Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis

Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis

Antovic, A.; Bruchfeld, A.; Ekland, J.; Lovstrom, B. et al.

Ingår i Scandinavian Journal of Rheumatology, s. 418-423, 2023

• DOI för Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis
• Ladda ner fulltext (pdf) av Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis

Hellbacher, Erik; van Hoef, Vincent; Johansson, Alina; Knight, Ann et al.

Ingår i Frontiers in Immunology, 2025

• DOI för The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
• Ladda ner fulltext (pdf) av The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis

In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes

Lindberg, Hanna; Knight, Ann; Hellbacher, Erik; Norling, Olof et al.

Ingår i ACR Open Rheumatology, 2025

• DOI för In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes
• Ladda ner fulltext (pdf) av In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes

The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

Lundtoft, Christian; Knight, Ann; Meadows, Jennifer; Karlsson, Åsa et al.

Ingår i RMD Open, 2024

• DOI för The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population
• Ladda ner fulltext (pdf) av The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis

Sejersen, Kristina; Weitoft, Tomas; Knight, Ann; Lysholm, Jörgen et al.

Ingår i Rheumatology, 2023

• DOI för Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis
• Ladda ner fulltext (pdf) av Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis

Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis

Antovic, A.; Bruchfeld, A.; Ekland, J.; Lovstrom, B. et al.

Ingår i Scandinavian Journal of Rheumatology, s. 418-423, 2023

• DOI för Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis
• Ladda ner fulltext (pdf) av Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis

Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study

Molina, Berengere; Padoan, Roberto; Urban, Maria Letizia; Novikov, Pavel et al.

Ingår i Annals of the Rheumatic Diseases, s. 1587-1593, 2023

• DOI för Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study

Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk?: A comparative effectiveness study of b/tsDMARDs in Sweden

Bower, Hannah; Frisell, Thomas; di Giuseppe, Daniela; Delcoigne, Benedicte et al.

Ingår i RMD Open, 2023

• DOI för Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk?: A comparative effectiveness study of b/tsDMARDs in Sweden
• Ladda ner fulltext (pdf) av Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk?: A comparative effectiveness study of b/tsDMARDs in Sweden

Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis

Ekman, Diana; Sennblad, Bengt; Knight, Ann; Karlsson, Åsa et al.

Ingår i Rheumatology, s. 3213-3218, 2023

• DOI för Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis
• Ladda ner fulltext (pdf) av Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis

High levels of interleukin-6 in rheumatoid arthritis joint fluids can stimulate local production of C-reactive protein resulting in elevated circulating levels

Rönnelid, Johan; Knight, Ann; Lysholm, Jörgen; Manivel, Vivek Anand et al.

Ingår i Joint Bone Spine, 2021

• DOI för High levels of interleukin-6 in rheumatoid arthritis joint fluids can stimulate local production of C-reactive protein resulting in elevated circulating levels

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sattui, Sebastian E.; Conway, Richard; Putman, Michael S.; Seet, Andrea M. et al.

Ingår i The Lancet Rheumatology, 2021

• DOI för Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Are Farming and Animal Exposure Risk Factors for the Development of Granulomatosis with Polyangiitis? Environmental Risk Factors Revisited: A Case-control Study

Lindberg, Hanna; Colliander, Caroline; Nise, Lena; Dahlqvist, Johanna et al.

Ingår i Journal of Rheumatology, s. 894-897, 2021

• DOI för Are Farming and Animal Exposure Risk Factors for the Development of Granulomatosis with Polyangiitis? Environmental Risk Factors Revisited: A Case-control Study

Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA

Dahlqvist, Johanna; Ekman, Diana; Sennblad, Bengt; Kozyrev, Sergey V. et al.

Ingår i Rheumatology, s. 3461-3470, 2021

• DOI för Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA
• Ladda ner fulltext (pdf) av Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Hellbacher, Erik; Hjorton, Karin; Backlin, Carin; Enblad, Gunilla et al.

Ingår i Acta Oncologica, s. 1655-1659, 2019

• DOI för Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

Lyons, Paul A.; Peters, James E.; Alberici, Federico; Liley, James et al.

Ingår i Nature Communications, 2019

• DOI för Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
• Ladda ner fulltext (pdf) av Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

A case of systemic lupus erythematosus with C1q deficiency, increased serum interferon-a levels and high serum interferogenic activity

Bolin, Karin; Eloranta, Maija-Leena; Kozyrev, Sergey V.; Dahlqvist, Johanna et al.

Ingår i Rheumatology, s. 918-919, 2019

• DOI för A case of systemic lupus erythematosus with C1q deficiency, increased serum interferon-a levels and high serum interferogenic activity

Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis

Sohrabian, Azita; Mathsson Alm, Linda; Hansson, Monika; Knight, Ann et al.

Ingår i Annals of the Rheumatic Diseases, s. 1345-1353, 2018

• DOI för Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis
• Ladda ner fulltext (pdf) av Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis

Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab

Knight, Ann; Pauksen, Karlis; Nordmark, Gunnel; Eva, Kumlien

Ingår i Rheumatology, s. 855-856, 2017

• DOI för Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab

Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies

Weitoft, Tomas; Larsson, Anders; Saxne, T; Manivel, Vivek Anand et al.

Ingår i Scandinavian Journal of Rheumatology, s. 346-352, 2017

• DOI för Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies

Malignant Lymphoma In Granulomatosis With Polyangiitis

Hellbacher, Erik; Hjorton, Karin; Sundström, Christer; Baecklund, Eva et al.

Ingår i Rheumatology, 2017

Number Of Peptide-Specific Anti-Citrullinated Peptide Antibodies In Synovial Fluid And In Synovial Fluid Immune Complexes Associate With Degree Of Radiological Destruction And Response To Triamcinolone Hexacetonide For Knee Synovitis In Rheumatoid Arthritis

Sohrabian, Azita; Mathsson Alm, Linda; Hansson, M.; Lysholm, J. et al.

Ingår i Annals of the Rheumatic Diseases, s. 509-510, 2017

• DOI för Number Of Peptide-Specific Anti-Citrullinated Peptide Antibodies In Synovial Fluid And In Synovial Fluid Immune Complexes Associate With Degree Of Radiological Destruction And Response To Triamcinolone Hexacetonide For Knee Synovitis In Rheumatoid Arthritis

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission

Chatzidionysiou, Katerina; Turesson, Carl; Teleman, Annika; Knight, Ann et al.

Ingår i RMD Open, 2016

• DOI för A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission
• Ladda ner fulltext (pdf) av A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission

Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study

Hertzell, Katarina Brodin; Pauksens, Karlis; Rombo, Lars; Knight, Ann et al.

Ingår i Vaccine, s. 650-655, 2016

• DOI för Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study

Late-onset neutropenia after rituximab in ANCA-associated vasculitis

Knight, Ann; Sundström, Y.; Börjesson, O.; Bruchfeld, A. et al.

Ingår i Scandinavian Journal of Rheumatology, s. 404-407, 2016

• DOI för Late-onset neutropenia after rituximab in ANCA-associated vasculitis

Lymphoma in Patients with Granulomatosis with Polyangiitis

Hjorton, Karin; Hellbacher, Erik; Sundstrom, Christer; Baecklund, Eva et al.

Ingår i Arthritis & Rheumatology, 2015

• DOI för Lymphoma in Patients with Granulomatosis with Polyangiitis

Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies

Weitoft, Tomas; Larsson, Anders; Manivel, Vivek A; Lysholm, Jörgen et al.

Ingår i Rheumatology, s. 1923-1928, 2015

• DOI för Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies

Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Knight, Ann; Hjorton, Karin; Sundström, Christer; Höglund, Martin et al.

Ingår i Journal of Rheumatology, s. 690-694, 2015

• DOI för Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis-a case series.

Knight, A; Hallenberg, H; Baecklund, Eva

Ingår i Clinical Rheumatology, s. 841-848, 2014

• DOI för Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis-a case series.
• Ladda ner fulltext (pdf) av Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis-a case series.

Late-onset neutropaenia in ANCA-associated vasculitis after rituximab treatment

Knight, Ann; Bruchfeld, A.; Gunnarsson, I.

Ingår i Scandinavian Journal of Rheumatology, s. 50-51, 2014

Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis: a prospective cohort study

Weitoft, Tomas; Rönnelid, Johan; Knight, Ann; Lysholm, Jörgen et al.

Ingår i Arthritis Research & Therapy, 2014

• DOI för Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis: a prospective cohort study
• Ladda ner fulltext (pdf) av Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis: a prospective cohort study

Scalp necrosis as a late sign of giant-cell arteritis

Alimohammadi, Mohammad; Knight, Ann

Ingår i Case reports in immunology, 2013

• DOI för Scalp necrosis as a late sign of giant-cell arteritis

Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study

Nordström, Dan; Knight, Ann; Luukkainen, Reijo; van Vollenhoven, Ronald et al.

Ingår i Journal of Rheumatology, s. 2008-2011, 2012

• DOI för Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study

A Multicenter, Randomized, Controlled, Open-Label Pilot Study of the Feasibility of Discontinuation of Adalimumab in Rheumatoid Arthritis Patients in Stable Clinical Remission

Chatzidionysiou, Katerina; Turesson, Carl; Teleman, Annika; Knight, Ann et al.

Ingår i Arthritis and Rheumatism, 2012

Occupational risk factors for Wegener's granulomatosis: a case-control study

Knight, Ann; Sandin, Sven; Askling, Johan

Ingår i Annals of the Rheumatic Diseases, s. 737-740, 2010

• DOI för Occupational risk factors for Wegener's granulomatosis: a case-control study

Increased Risk of Autoimmune Disease in Families with Wegener's Granulomatosis

Knight, Ann; Sandin, Sven; Askling, Johan

Ingår i Journal of Rheumatology, s. 2553-2558, 2010

• DOI för Increased Risk of Autoimmune Disease in Families with Wegener's Granulomatosis

What is the significance in routine care of c-ANCA/PR3-ANCA in the abscence of systemic vasculitis?: A case series

Knight, Ann; Ekbom, Anders; Brandt, Lena; Askling, Johan

Ingår i Clinical and Experimental Rheumatology, 2008

Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease

Knight, Ann; Sandin, Sven; Askling, Johan

Ingår i Arthritis and Rheumatism, s. 302-7, 2008

• DOI för Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease

Increasing Incidence of Wegener´s granulomatosis in Sweden 1975-2001

Knight, Ann; Ekbom, Anders; Brandt, Lena; Askling, Johan

Ingår i Journal of Rheumatology, s. 2060-2063, 2006

Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide

Knight, Ann; Askling, Johan; Fredrik, Granath; Pär, Sparen et al.

Ingår i Annals of the Rheumatic Diseases, s. 1307-1311, 2004

• DOI för Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide

Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis

Turesson, C.; Börjesson, O.; Larsson, K.; Mohammad, A. J. et al.

Ingår i Scandinavian Journal of Rheumatology, s. 259-265, 2019

• DOI för Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis
• Ladda ner fulltext (pdf) av Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis

Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations

Kaiser, Christina; Knight, Ann; Nordström, Dan; Pettersson, Tom et al.

Ingår i Rheumatology International, s. 295-299, 2012

• DOI för Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations

Clinical and Epidemiological Studies of Wegener´s Granulomatosis

Knight, Ann

2007

• Ladda ner fulltext (pdf) av Clinical and Epidemiological Studies of Wegener´s Granulomatosis